KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $555.2 million.

  • Medpace Holdings' Operating Expenses rose 3501.12% to $555.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 2004.08%. This contributed to the annual value of $2.0 billion for FY2025, which is 2004.08% up from last year.
  • Per Medpace Holdings' latest filing, its Operating Expenses stood at $555.2 million for Q4 2025, which was up 3501.12% from $518.1 million recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' Operating Expenses ranged from a high of $555.2 million in Q4 2025 and a low of $212.4 million during Q1 2021
  • Its 5-year average for Operating Expenses is $366.6 million, with a median of $394.7 million in 2023.
  • Per our database at Business Quant, Medpace Holdings' Operating Expenses increased by 3.16% in 2024 and then surged by 3501.12% in 2025.
  • Medpace Holdings' Operating Expenses (Quarter) stood at $253.7 million in 2021, then rose by 25.22% to $317.7 million in 2022, then rose by 29.41% to $411.1 million in 2023, then rose by 0.03% to $411.2 million in 2024, then skyrocketed by 35.01% to $555.2 million in 2025.
  • Its Operating Expenses stands at $555.2 million for Q4 2025, versus $518.1 million for Q3 2025 and $477.0 million for Q2 2025.